Roche’s new interactive insulin pump system approved by FDA

Roche announced that it has received clearance from the U.S Food and Drug Administration (FDA) for the Accu-Chek Combo system for their insulin pump therapy. The Accu-Chek Combo system combines a blood glucose meter with an insulin pump which are able to exchange data in both directions via Bluetooth wireless technology. The meter enables user to test blood glucose level and allows for operating the insulin pump remotely that provides support in defining the right amount of insulin. It is supports therapy management and allows for a discreet insulin administration without the need to touch the pump.
insulin pump
free image hosting

Roche COO, Daneil O’Day said that the new insulin pump system will soon available in the U.S this year. The Accu-Chek Combo system has been launched in several European and Asia Pasific country including France, UK, Australia and Germany.

About the Accu-Chek Combo system:
In addition to being discreet and easy-to-use, the Accu-Chek Combo system also features:

  • Bluetooth technology for two-way wireless communication between the smart meter and the insulin pump;
  • A full-color display that brings to life blood glucose data, insulin dose information and pump settings;
  • A bolus advice function on the meter to allow users to easily calculate and deliver a bolus without touching the pump;
  • Flexibility to adjust the basal rate to as low as 0.05 units per hour – in increments as precise as 0.01 units; and
  • An insulin cartridge that holds up to 315 units of insulin, the largest capacity among pumps sold in the U.S.
  • About Roche Diabetes Care
    Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 35 years, the Accu-Chek brand has been dedicated to enable people with diabetes to live life as normal and active as possible as well as to empower healthcare professionals manage their patients’ condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management spanning from blood glucose monitoring through information management to insulin delivery. The Accu-Chek brand encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – leading to an improved medical outcome.

    More Information visit :-

    Source Info :  Yahoo Finance

    It is great for Roche to get approval from FDA. Hopefully the insulin pump will help diabetes patient.

    Be the first to comment

    Leave a Reply

    Your email address will not be published.


    This site uses Akismet to reduce spam. Learn how your comment data is processed.